Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants

被引：27

作者：

Olomu N. ^{[1
]}

Kulkarni R. ^{[2
]}

Manco-Johnson M. ^{[3
]}

机构：

[1] Dept. of Pediatr./Human Development, Division of Neonatology, Michigan University, East Lansing, MI 48909-7980

[2] Dept. of Pediatr./Human Development, Division of Hematology-Oncology, Michigan State University, East Lansing, MI

[3] Mountain States Regional Hemophilia, Thrombosis Center, Univ. of Colorado Hlth. Sci. Center, Aurora, CO

来源：

Journal of Perinatology | 2002年 / 22卷 / 8期

关键词：

D O I：

10.1038/sj.jp.7210787

中图分类号：

学科分类号：

摘要：

Clinically apparent pulmonary hemorrhage (PH) occurs in 5% to 7% of very low birth weight (VLBW) infants with respiratory distress syndrome (RDS). It is associated with mortality rate as high as 50% and significant pulmonary and central nervous system morbilities. There is no consensus on treatment modality. We present two VLBW infants with severe PH that did not respond to conventional treatment but were successfully treated with activated recombinant factor VII (rRVIIa). No untoward side effects were noted.

引用

页码：672 / 674

页数：2

共 50 条

[31] Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia
Ansari, Amir M.
Khorasanchi, Adam
Faghihimehr, Armaghan
Toor, Amir
CLINICAL CASE REPORTS, 2021, 9 (10):
[32] Treatment of acute pulmonary haemorrhage in extremely preterm infants with recombinant activated factor VII
Poralla, Christine
Hertfelder, Hans-Joerg
Oldenburg, Johannes
Mueller, Andreas
Bartmann, Peter
Heep, Axel
ACTA PAEDIATRICA, 2010, 99 (02) : 298 - 300
[33] PROLONGED RECOMBINANT ACTIVATED FACTOR-VII (RFVIIA) TREATMENT FOR SEVERE BLEEDING IN A FACTOR-IX-DEFICIENT PATIENT WITH AN INHIBITOR
SCHMIDT, ML
SMITH, HE
GAMERMAN, S
DIMICHELE, D
GLAZER, S
SCOTT, JP
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (03) : 460 - 463
[34] RECOMBINANT ERYTHROPOIETIN IN VERY-LOW-BIRTH-WEIGHT INFANTS
BECK, D
CALAME, A
MASSEREY, E
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (10) : 676 - 677
[35] The emerging role of recombinant activated Factor VII (rFVIIa) in the treatment of blunt traumatic haemorrhage
Rizoli, SB
Chughtai, T
EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (01) : 73 - 81
[36] Delivery mode and severe intraventricular hemorrhage in single, very low birth weight, vertex infants
Riskin, Arieh
Riskin-Mashiah, Shlomit
Bader, David
Kugelman, Amir
Lerner-Geva, Liat
Boyko, Valentina
Reichman, Brian
OBSTETRICS AND GYNECOLOGY, 2008, 112 (01) : 21 - 28
[37] Recombinant activated factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
Baudo, F
Gaidano, G
Carloni, MT
Coppola, A
Fariciotti, A
Iorio, A
Marietta, M
Marongiu, F
Mazzucconi, MG
Miraglia, E
Schiavoni, M
Schinco, PC
BLOOD, 2002, 100 (11) : 100B - 100B
[38] Early Vital Sign Differences in Very Low Birth Weight Infants with Severe Intraventricular Hemorrhage
Zanelli, Santina A.
Abubakar, Maryam
Andris, Robert
Patwardhan, Kavita
Fairchild, Karen D.
Vesoulis, Zachary A.
AMERICAN JOURNAL OF PERINATOLOGY, 2023, 40 (11) : 1193 - 1201
[39] A predictive clinical model for moderate to severe intraventricular hemorrhage in very low birth weight infants
Rachel M. Weinstein
Charlamaine Parkinson
Allen D. Everett
Ernest M. Graham
Dhananjay Vaidya
Frances J. Northington
Journal of Perinatology, 2022, 42 : 1374 - 1379
[40] A predictive clinical model for moderate to severe intraventricular hemorrhage in very low birth weight infants
Weinstein, Rachel M.
Parkinson, Charlamaine
Everett, Allen D.
Graham, Ernest M.
Vaidya, Dhananjay
Northington, Frances J.
JOURNAL OF PERINATOLOGY, 2022, 42 (10) : 1374 - 1379

← 1 2 3 4 5 →